Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
01-03 September, 2025
Process DevelopmentProcess Development
Not Confirmed
Not Confirmed
01 September, 2025
Not Confirmed
Not Confirmed
01-03 September, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
01-03 September, 2025
Process DevelopmentProcess Development
Industry Trade Show
Not Confirmed
01 September, 2025
Industry Trade Show
Not Confirmed
01-03 September, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/50-years-of-innovation-mikart-s-legacy-and-what-s-next-in-cdmo-excellence
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/fda-approvals-drop-24-in-h1-2025-gsk-s-uti-med-vertex-s-non-opioid-painkiller-lead-pack-of-first-in-class-meds
19 Aug 2025
// PHARMAWEB
https://www.pharmiweb.com/press-release/2025-08-19/ensysce-biosciences-geoff-birkett-to-chair-the-fierce-new-product-planning-summit-2025
13 Aug 2025
// PHARMAWEB
https://www.pharmiweb.com/press-release/2025-08-13/ensysce-biosciences-reports-second-quarter-2025-financial-results-and-latest-program-updates
31 Jul 2025
// PHARMAWEB
https://www.pharmiweb.com/press-release/2025-07-31/ensysce-biosciences-advances-breakthrough-opioid-with-built-in-overdose-protection-following-positiv
16 Jul 2025
// ACCESSWIRE
https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/ensysce-biosciences-initiates-pivotal-phase-3-study-of-pf614-a-next-g-1049119
24 Jun 2025
// ACCESSWIRE
https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/ensysce-biosciences-accelerates-pf614-mpar-102-study-with-full-enroll-1042177
04 Jun 2025
// ACCESSWIRE
https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/ensysce-biosciences-awarded-5.3-million-in-continued-nida-support-to-1035140
ABOUT THIS PAGE